Treating hematologic malignancies with engineered T cells
This article explores new targets in solid tumors for treating patients with hematologic malignancies.
Stay updated with breaking news from T Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article explores new targets in solid tumors for treating patients with hematologic malignancies.
A new form of gene therapy uses CRISPR editing to create T-cells that hunt cancer cells. Although still in its very early stages, the treatment offers hope for those suffering from untreatable cancer.
Scientists at Australia’s Garvan Institute of Medical Research have revealed how cancer cells evade the immune system and render immunotherapies ineffective.
Inflammation is a complicated and important part of how the immune system responds to threats to the body. But when the inflammatory response goes awry, it can lead to serious problems.
Dr. Chris Alan Shoemaker, a Canadian doctor with 45 years of experience in emergency medicine, family practice and on military bases, has made an alarming claim that the five-year survival rate [...]